Acuta Capital Partners’s Spectranetics Corp SPNC Stock Holding History

Acuta Capital Partners’s Portfolio SPNC Stock Details SPNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,500	Closed	-$674K	–	84
2016 Q4	$674K	Buy	+27,500	New	+$647K	0.25%	39
2015 Q4	–	Sell	-260,000	Closed	-$3.06M	–	80
2015 Q3	$3.06M	Buy	260,000 +10,000	+4%	+$179K	1.77%	20
2015 Q2	$5.75M	Buy	+250,000	New	+$6.98M	3.56%	8

Acuta Capital Partners's SPNC Position: Q1 2017 in Review

Acuta Capital Partners sold out of Spectranetics Corp (SPNC) in Q1 2017, closing a stake of 27,500 shares — an estimated $674K sold.

Acuta Capital Partners first reported a position in SPNC in Q2 2015 and held it in 3 quarters. The position peaked at $5.75M in Q2 2015. 146 funds tracked by Wall St. Rank hold SPNC as of Q1 2017.

Acuta Capital Partners reported no remaining Spectranetics Corp position as of Q1 2017 after selling out during the quarter.
Acuta Capital Partners sold 27,500 Spectranetics Corp shares in Q1 2017, an estimated $674K.
Acuta Capital Partners first reported a position in Spectranetics Corp in Q2 2015 and held it in 3 quarters.
Acuta Capital Partners's Spectranetics Corp position peaked at $5.75M in Q2 2015.
146 funds tracked by Wall St. Rank held Spectranetics Corp as of Q1 2017.

Based on Acuta Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.